Transplant Evaluation and Acute Posttransplant Care of the Adult with Congenital Heart Disease

  • Vanessa Wong
  • Juan AlejosEmail author
Part of the Congenital Heart Disease in Adolescents and Adults book series (CHDAA)


As of 2010 there were approximately 2.4 million people in the United States living with congenital heart disease of which 1.4 million are adults (Gilboa SM, Devine OJ, Kucik JE, Oster ME, Riehle-Colarusso T, Nembhard WN, Xu P, Correa A, Jenkins K, Marelli AJ, Circulation. 134:101–9, 2016). With the advancement in prenatal detection, early surgical intervention, and improved medical management, more children with congenital heart disease are living into adulthood. While there has been significant advancement in palliative and corrective surgical repairs of congenital heart disease, congestive heart failure still remains a significant cause for morbidity and mortality in adults with congenital heart disease. As a result, 10–20% of adults with congenital heart disease may require heart transplantation, and they account for approximately 3% of all adult heart transplants (Goldberg SW, Fisher SA, Wehman B, Mehra MR, The Journal of Heart and Lung Transplantation. 33:873–7, 2014). Although congenital heart disease is a small percentage of causes for heart transplant, the percentage of heart transplants for adults with congenital heart disease has nearly doubled in the last 18 years and will likely continue to increase as more children with congenital heart disease survive into adulthood. Much of the transplant evaluation is similar in adults with congenital heart disease and those without; however, there are unique pathologic and physiologic characteristics of those with congenital heart disease that require special consideration in the evaluation process prior to listing for heart transplantation and the postoperative care after transplantation. In this chapter we will discuss the evaluation process for transplant and the immediate postoperative management of the adult congenital heart disease population who receive a heart transplantation.


Adult congenital heart disease (ACHD) Heart transplant Transplant evaluation Postoperative care Graft failure Arrhythmias Immunosuppression 


  1. 1.
    Gilboa SM, Devine OJ, Kucik JE, Oster ME, Riehle-Colarusso T, Nembhard WN, Xu P, Correa A, Jenkins K, Marelli AJ. Congenital heart defects in the United States: estimating the magnitude of the affected population in 2010. Circulation. 2016;134(2):101–9.CrossRefGoogle Scholar
  2. 2.
    Goldberg SW, Fisher SA, Wehman B, Mehra MR. Adults with congenital heart disease and heart transplantation: optimizing outcomes. J Heart Lung Transplant. 2014;33(9):873–7.CrossRefGoogle Scholar
  3. 3.
    Mancini D, Lietz K. Selection of cardiac transplantation candidates in 2010. Circulation. 2010;122(2):173–83.CrossRefGoogle Scholar
  4. 4.
    Mehra MR, Canter CE, Hannan MM, Semigran MJ, Uber PA, Baran DA, Danziger-Isakov L, Kirklin JK, Kirk R, Kushwaha SS, Lund LH. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: a 10-year update. J Heart Lung Transplant. 2016;35(1):1):1–23.CrossRefGoogle Scholar
  5. 5.
    Mehra MR, Kobashigawa J, Starling R, Russell S, Uber PA, Parameshwar J, Mohacsi P, Augustine S, Aaronson K, Barr M. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates—2006. J Heart Lung Transplant. 2006;25(9):1024–42.CrossRefGoogle Scholar
  6. 6.
    Hoyel L, et al. Heart transplantation in adults with congenital heart disease. Arch Cardiovasc Dis. 2017;110:346. CrossRefGoogle Scholar
  7. 7.
    Burchill LJ. Heart transplantation in adult congenital heart disease. Heart. 2016;102(23):1871–7.CrossRefGoogle Scholar
  8. 8.
    Costard-Jäckle A, Fowler MB. Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. J Am Coll Cardiol. 1992;19(1):48–54.CrossRefGoogle Scholar
  9. 9.
    Giglia TM, Humpl T. Preoperative pulmonary hemodynamics and assessment of operability: is there a pulmonary vascular resistance that precludes cardiac operation? Pediatr Crit Care Med. 2010;11:S57–69.CrossRefGoogle Scholar
  10. 10.
    Krishnan US, Lamour JM, Hsu DT, Kichuk MR, Donnelly CM, Addonizio LJ. Management of aortopulmonary collaterals in children following cardiac transplantation for complex congenital heart disease. J Heart Lung Transplant. 2004;23(5):564–9.CrossRefGoogle Scholar
  11. 11.
    Morrow WR, Frazier E, Naftel DC. Survival after listing for cardiac transplantation in children. Prog Pediatr Cardiol. 2000;11(2):99–105.CrossRefGoogle Scholar
  12. 12.
    Lindsay I, Johnson J, Everitt MD, Hoffman J, Yetman AT. Impact of liver disease after the Fontan operation. Am J Cardiol. 2015;115(2):249–52.CrossRefGoogle Scholar
  13. 13.
    Rychik J, Veldtman G, Rand E, Russo P, Rome JJ, Krok K, Goldberg DJ, Cahill AM, Wells RG. The precarious state of the liver after a Fontan operation: summary of a multidisciplinary symposium. Pediatr Cardiol. 2012;33(7):1001–12.CrossRefGoogle Scholar
  14. 14.
    Assenza GE, Graham DA, Landzberg MJ, Valente AM, Singh MN, Bashir A, Fernandes S, Mortele KJ, Ukomadu C, Volpe M, Wu F. MELD-XI score and cardiac mortality or transplantation in patients after Fontan surgery. Heart. 2013;99(7):491–6.CrossRefGoogle Scholar
  15. 15.
    Costanzo MR, Dipchand A, Starling R, Anderson A, Chan M, Desai S, Fedson S, Fisher P, Gonzales-Stawinski G, Martinelli L, McGiffin D, Smith J, Taylor D, Meiser B, Webber S, Baran D, Carboni M, Dengler T, Feldman D, Frigerio M, Kfoury A, Kim D, Kobashigawa J, Shullo M, Stehlik J, Teuteberg J, Uber P, Zuckermann A, Hunt S, Burch M, Bhat G, Canter C, Chinnock R, Crespo-Leiro M, Delgado R, Dobbels F, Grady K, Kao W, Lamour J, Parry G, Patel J, Pini D, Towbin J, Wolfel G, Delgado D, Eisen H, Goldberg L, Hosenpud J, Johnson M, Keogh A, Lewis C, O’Connell J, Rogers J, Ross H, Russell S, Vanhaecke J, International Society of Heart and Lung Transplantation Guidelines. The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J Heart Lung Transplant. 2010;29(8):914–56.CrossRefGoogle Scholar
  16. 16.
    Lund LH, Edwards LB, Kucheryavaya AY, Benden C, Dipchand AI, Goldfarb S, Levvey BJ, Meiser B, Rossano JW, Yusen RD, Stehlik J. The Registry of the International Society for Heart and Lung Transplantation: thirty-second official adult heart transplantation report—2015; focus theme: early graft failure. J Heart Lung Transplant. 2015;34(10):1244.CrossRefGoogle Scholar
  17. 17.
    Chew HC, Kumarasinghe G, Iyer A, Hicks M, Gao L, Doyle A, Jabbour A, Dhital K, Granger E, Jansz P, Hayward C. Primary graft dysfunction after heart transplantation. Curr Transplant Rep. 2014;1:257–65.CrossRefGoogle Scholar
  18. 18.
    Iyer A, Kumarasinghe G, Hicks M, Watson A, Gao L, Doyle A, Keogh A, Kotlyar E, Hayward C, Dhital K, Granger E. Primary graft failure after heart transplantation. J Transplant. 2011;2011:1, Article ID 175768, 9 pCrossRefGoogle Scholar
  19. 19.
    Rodriguez-Lopez J. Pulmonary hypertension in adult congenital heart disease. Curr Treat Options Cardiovasc Med. 2014;16(8):1–2.CrossRefGoogle Scholar
  20. 20.
    Stecker EC, Strelich KR, Chugh SS, Crispell K, McAnulty JH. Arrhythmias after orthotopic heart transplantation. J Card Fail. 2005;11(6):464–72.CrossRefGoogle Scholar
  21. 21.
    Söderlund C, Rådegran G. Immunosuppressive therapies after heart transplantation—the balance between under-and over-immunosuppression. Transplant Rev. 2015;29(3):181–9.CrossRefGoogle Scholar
  22. 22.
    Agüero J, Almenar L, Martınez-Dolz L, Chamorro C, Moro J, Rueda J, Arnau MA, Zorio E, Izquierdo M, Salvador A. Influence of immunosuppression regimen on heart transplantation survival. Transplant Proc. 2006;38(8):2550–2.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  1. 1.UCLA Mattel Children’s HospitalLos AngelesUSA

Personalised recommendations